316 related articles for article (PubMed ID: 17724134)
21. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
[TBL] [Abstract][Full Text] [Related]
22. Why does somatic hypermutation by AID require transcription of its target genes?
Storb U
Adv Immunol; 2014; 122():253-77. PubMed ID: 24507160
[TBL] [Abstract][Full Text] [Related]
23. Amino-terminal phosphorylation of activation-induced cytidine deaminase suppresses c-myc/IgH translocation.
Gazumyan A; Timachova K; Yuen G; Siden E; Di Virgilio M; Woo EM; Chait BT; Reina San-Martin B; Nussenzweig MC; McBride KM
Mol Cell Biol; 2011 Feb; 31(3):442-9. PubMed ID: 21135131
[TBL] [Abstract][Full Text] [Related]
24. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
25. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences.
Dudley DD; Chaudhuri J; Bassing CH; Alt FW
Adv Immunol; 2005; 86():43-112. PubMed ID: 15705419
[TBL] [Abstract][Full Text] [Related]
26. Analysis of 6912 unselected somatic hypermutations in human VDJ rearrangements reveals lack of strand specificity and correlation between phase II substitution rates and distance to the nearest 3' activation-induced cytidine deaminase target.
Ohm-Laursen L; Barington T
J Immunol; 2007 Apr; 178(7):4322-34. PubMed ID: 17371989
[TBL] [Abstract][Full Text] [Related]
27. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
[TBL] [Abstract][Full Text] [Related]
28. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
Silva S; Wiener F; Klein G; Janz S
Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
[TBL] [Abstract][Full Text] [Related]
29. Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas.
Otto C; Scholtysik R; Schmitz R; Kreuz M; Becher C; Hummel M; Rosenwald A; Trümper L; Klapper W; Siebert R; Küppers R;
Genes Chromosomes Cancer; 2016 Dec; 55(12):932-943. PubMed ID: 27356265
[TBL] [Abstract][Full Text] [Related]
30. Alternative end-joining in follicular lymphomas' t(14;18) translocation.
Marculescu R; Le T; Böcskör S; Mitterbauer G; Chott A; Mannhalter C; Jaeger U; Nadel B
Leukemia; 2002 Jan; 16(1):120-6. PubMed ID: 11840271
[TBL] [Abstract][Full Text] [Related]
31. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
[TBL] [Abstract][Full Text] [Related]
32. APE1 is dispensable for S-region cleavage but required for its repair in class switch recombination.
Xu J; Husain A; Hu W; Honjo T; Kobayashi M
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17242-7. PubMed ID: 25404348
[TBL] [Abstract][Full Text] [Related]
33. Myc translocations in B cell and plasma cell neoplasms.
Janz S
DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
[TBL] [Abstract][Full Text] [Related]
34. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations.
Robbiani DF; Bothmer A; Callen E; Reina-San-Martin B; Dorsett Y; Difilippantonio S; Bolland DJ; Chen HT; Corcoran AE; Nussenzweig A; Nussenzweig MC
Cell; 2008 Dec; 135(6):1028-38. PubMed ID: 19070574
[TBL] [Abstract][Full Text] [Related]
35. Ongoing hypermutation in the Ig V(D)J gene segments and c-myc proto-oncogene of an AIDS lymphoma segregates with neoplastic B cells at different sites: implications for clonal evolution.
Ikematsu H; Cerutti A; Zan H; Knowles DM; Ikematsu W; Casali P
Hum Immunol; 2000 Dec; 61(12):1242-53. PubMed ID: 11163079
[TBL] [Abstract][Full Text] [Related]
36. Translocation of an antibody transgene requires AID and occurs by interchromosomal switching to all switch regions except the mu switch region.
Shansab M; Eccleston JM; Selsing E
Eur J Immunol; 2011 May; 41(5):1456-64. PubMed ID: 21469111
[TBL] [Abstract][Full Text] [Related]
37. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
Komori A; Xu Z; Wu X; Zan H; Casali P
Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
[TBL] [Abstract][Full Text] [Related]
38. Apurinic/apyrimidinic endonuclease 1 (APE1) is dispensable for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation in the immunoglobulin gene.
Islam H; Kobayashi M; Honjo T
Int Immunol; 2019 Jul; 31(8):543-554. PubMed ID: 30877298
[TBL] [Abstract][Full Text] [Related]
39. Indirect and direct evidence for DNA double-strand breaks in hypermutating immunoglobulin genes.
Jacobs H; Rajewsky K; Fukita Y; Bross L
Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):119-25. PubMed ID: 11205324
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
Pérez-Durán P; de Yebenes VG; Ramiro AR
Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
